Evidence map›Paper›PMID 35801373›Full record

ArticleCancer reports (Hoboken, N.J.)2022

Low-grade serous carcinoma detected from intraoperative peritoneal washings: Cytological findings and detection of KRAS mutation.

Eriko Yamamoto, Kenji Warigaya, Yuichi Kinoshita, Ayana Yamamoto, Shin-Ichi Murata

Open access · goldAbstract readCase Reports
In one paragraph

Article in Cancer reports (Hoboken, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Eriko YamamotoDivision of Diagnostic Pathology, Department of Central Laboratory Medicine, Wakayama Medical University Hospital, Wakayama, Wakayama, Japan.
Kenji WarigayaDivision of Diagnostic Pathology, Shin-kuki General Hospital, Kuki, Saitama, Japan.
Yuichi KinoshitaDivision of Diagnostic Pathology, Department of Central Laboratory Medicine, Wakayama Medical University Hospital, Wakayama, Wakayama, Japan.ORCID 0000-0002-0463-1091
Ayana YamamotoDivision of Diagnostic Pathology, Department of Central Laboratory Medicine, Wakayama Medical University Hospital, Wakayama, Wakayama, Japan.
Shin-Ichi MurataDivision of Diagnostic Pathology, Department of Central Laboratory Medicine, Wakayama Medical University Hospital, Wakayama, Wakayama, Japan.
Wakayama Medical University · JPShimonoseki City Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLow-grade serous carcinoma (LGSC) of the ovary, which is extremely rare tumor, has better prognosis than high-grade serous carcinoma (HGSC). Genetic backgrounds of those are different, so that LGSC usually shows KRAS or BRAF mutation, whereas HGSC does not show such mutations. Since treatment strategies of those are different, differential pathological diagnosis between LGSC and HGSC is very important. CASE: We report a case of LGSC that was diagnosed by both cytological findings and genetic analysis using small amount cells from cytological specimen. The 30-year-old Japanese woman with bilateral ovarian tumors underwent salpingo-oopherectomy. The peritoneal washing cytologic specimen and touched cytologic specimen from the tumor included non-complex clusters with psammoma bodies composed of tumor cells with mild to moderate atypia and without bizarre nuclei. The ovarian tumor was histologically diagnosed as LGSC. The genetic analysis that was done using exfoliated cells from peritoneal washings specimen by idensy™, detected KRAS mutation at codon 12/13.

conclusionThe genetic investigation using cytological specimen as well as characteristic cytological findings were useful to make differential diagnosis between LGSC and HGSC.

Indexed as

Cystadenocarcinoma, SerousOvarian NeoplasmsPeritoneal NeoplasmsAdultFemaleHumansMutationNeoplasm GradingProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)KRAS protein, humanProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)cytological findingsKRAS mutationlow-grade serous carcinoma (LGSC)ovaryperitoneal washings

Identifiers

PMID35801373
PMCPMC9575480
OpenAlexW4284878762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.